Tissue microarray constructs to predict a response to chemoradiation in rectal cancer

Sergio Huerta, John Hrom, Xiaohuan Gao, Debabrata Saha, Thomas Anthony, Henry Reinhart, Payal Kapur

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Purpose: To identify, using tissue microarray (TMA), an immunohistochemical panel predictive of response to ionizing radiation (IR) in rectal cancer. Methods: TMA constructs were prepared from archived stage II/III rectal tumors and matching adjacent mucosa (n= 38) from patients treated with pre-operative chemoradiation. Immunohistochemistry (IHC) was performed for MIB, Cyclin E, p21, p27, p53, survivin, Bcl-2, and BAX. Immunoreactivity along with clinical variables was subjected to univariate and forward stepwise logistic regression analyses. Results: Pathological complete response (pCR) was 23.9%. The number of positive lymph nodes obtained in the resected specimen was associated with pCR. Immunoreactivity for MIB (Sn 15%, Sp 65%, OR 0.33), p53 (Sn 3%, Sp 84%, OR 0.16), Bcl-2 (Sn 11%, Sp 74%, OR 0.35), and BAX (Sn 92%, Sp 80%, OR 46) was associated with pathological response (all p's < 0.001). Forward stepwise logistic regression analysis demonstrated that MIB was an independent predictor of a response to chemoradiation (p= 0.001). Conclusions: A combined panel of mediators of apoptosis alone or combined with clinical factors is a feasible approach that can be applied to rectal tumor biopsies to predict a response to chemoradiation. The most sensitive factor was BAX; while MIB independently predicted a response to chemoradiation.

Original languageEnglish (US)
Pages (from-to)679-684
Number of pages6
JournalDigestive and Liver Disease
Volume42
Issue number10
DOIs
StatePublished - Oct 1 2010

    Fingerprint

Keywords

  • BAX
  • Bcl-2
  • MIB
  • Number of lymph nodes
  • P53
  • Pathological complete response

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this